COVID 19 treatment through RNA interference

Authors

  • Yaseen Hussain College of Pharmaceutical Sciences, Soochow University, China
  • Amjad Hayat Khan Department of Allied Health Sciences, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Fazlullah Khan Faculty of pharmacy, Capital University of Science and Technology, Islamabad, Pakistan
  • Arbaz Ul Hussan Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Mubashir Kabir Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Iftikhar Ali Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Muhammad Sajjad Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Ayesha Sadaf Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Javeria Mukhtar Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Faiza Hassan Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan

DOI:

https://doi.org/10.53576/bashir.003.01.0044

Keywords:

Covid-19, siRNA, SARS-CoV-2, proteolytic enzymes, open reading frames, viral RNA-polymerase

Abstract

Not attempted because its a short commentary.

Downloads

Published

2022-12-12

Issue

Vol. 3 No. 1 (2022): J. Bashir Inst. Health Sci.

Section

Commentry

License

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). You are free to share, copy, and adapt this material for any purpose, including commercial use, as long as you give appropriate credit to the original author(s), provide a link to the license, and indicate if changes were made.